NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB
Published on June 11, 2010
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
|
(Check
One):
|
o Form
10-K
|
o Form
20-F
|
o Form
11-K
|
x Form
10-Q
|
o Form
10-D
|
|
o Form
N-SAR
|
|||||
|
For
Period Ended: 4-30-2010
o Transition Report
on Form 10-K
o Transition Report
on Form 20-F
o Transition Report
on Form 11-K
o Transition Report
on Form 10-Q
o Transition Report
on Form
N-SAR
|
|||||
For the
Transition Period Ended: N/A
Nothing
in this form shall be construed to imply that the Commission has verified any
information contained herein.
If the
notification relates to a portion of the filing checked above, identify the
Item(s) to which the notification relates: N/A
PART
I— REGISTRANT INFORMATION
Apollo
Medical Holdings, Inc.
Full Name
of Registrant
450 North
Brand Blvd, Suite 600
Address of Principal Executive Office (Street and Number)
Glendale,
California 91203
City, State and Zip Code
PART
II — RULES 12b-25(b) AND (c)
If the
subject report could not be filed without unreasonable effort or expense and the
registrant seeks relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate)
|
x
|
(a)
The reasons described in reasonable detail in Part III of this form could
not be eliminated without unreasonable effort or expense;
(b)
The subject annual report, semi-annual report, transition report on Form
10-K, Form 20-F, Form 11-K or Form N-SAR, Form N-CSR, or portion thereof,
will be filed on or before the fifteenth calendar day following the
prescribed due date; or the subject quarterly report or transition report
on Form 10-Q, or subject distribution report on Form 10-D, or portion
thereof, will be filed on or before the fifth calendar day following the
prescribed due date; and
(c)
The accountant's statement or other exhibit required by Rule 12b-25(c) has
been attached if applicable.
|
PART
III — NARRATIVE
State
below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q, N-SAR,
N-CSR, or the transition report or portion thereof, could not be filed within
the prescribed time period.
The
compilation, dissemination and review of the information required to be
presented in the Form 10-Q for the relevant period has imposed time constraints
that have rendered timely filing of the Form 10-Q impracticable without undue
hardship and expense to the registrant. The registrant expects to file such
report no later than five days after its original prescribed due
date.
PART
IV—OTHER INFORMATION
(1) Name
and telephone number of person to contact in regard to this
notification
|
A.
Noel DeWinter
|
(818)
|
507-4617
|
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
(2) Have
all other periodic reports required under Section 13 or 15(d) of the Securities
Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If answer is no,
identify report(s). x
Yes o No
(3) Is
it anticipated that any significant change in results of operation for the
corresponding period for the last fiscal year will be reflected by the earnings
statements to be included in the subject report or portion
thereof?
o
Yes x No
Apollo
Medical Holdings, Inc.
(Name of Registrant as Specified in Charter)
Has
caused this notification to be signed on its behalf by the undersigned hereunto
duly authorized.
|
Date:
June 11, 2010
|
By:
|
/s/ A.
Noel DeWinter
|
|
|
A.
Noel DeWinter
Chief
Financial Officer
|